Transient elastography in healthy subjects and factors influencing liver stiffness in non-alcoholic fatty liver disease: An Italian community-based population study

Digestive and Liver Disease

Volumn 48, Issue 11, 2016, Pages 1357-1363

  Conti, Fabio ^a   Vukotic, Ranka ^a   Foschi, Francesco Giuseppe ^b   Domenicali, Marco ^a   Giacomoni, Pierluigi ^b   Savini, Sara ^b   Lanzi, Arianna ^b   Dall'Aglio, Anna Chiara ^b   Saini, Gaia ^b   Matroroberto, Marianna ^a   Bernardi, Mauro ^a   Stefanini, Giuseppe Francesco ^b   Andreone, Pietro ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b Hospital of Faenza   (Italy)

Author keywords

Fibroscan; Insulin resistance; NAFLD; Normal value

Indexed keywords

ADULT; ANTHROPOMETRIC PARAMETERS; ARTICLE; CAUCASIAN; CLINICAL EVALUATION; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; ELASTOGRAPH; FEMALE; HUMAN; INSULIN RESISTANCE; LIVER FIBROSIS; LIVER STIFFNESS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NONALCOHOLIC FATTY LIVER; PRIORITY JOURNAL; STEATOSIS; TRANSIENT ELASTOGRAPHY; CASE CONTROL STUDY; COMPLICATION; DIAGNOSTIC IMAGING; ELASTOGRAPHY; ITALY; LIVER; LIVER CIRRHOSIS; MULTIVARIATE ANALYSIS; PATHOLOGY; STATISTICAL MODEL;

ADULT; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; ELASTICITY IMAGING TECHNIQUES; FEMALE; HUMANS; INSULIN RESISTANCE; ITALY; LIVER; LIVER CIRRHOSIS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NON-ALCOHOLIC FATTY LIVER DISEASE;

EID: 84981724352     PISSN: 15908658     EISSN: 18783562     Source Type: Journal    
DOI: 10.1016/j.dld.2016.07.020     Document Type: Article

References (45)

1. [1] European Association for Study of Liver, Asociacion Latinoamericana para el Estudio del Higado, EASL-ALEH Clinical Practice Guidelines: non-invasive tests for evaluation of liver disease severity and prognosis. Journal of Hepatology 63 (2015), 237–264.
2. [2] Sirli, R., Sporea, I., Tudora, A., et al. Transient elastographic evaluation of subjects without known hepatic pathology: does age change the liver stiffness?. Journal of Gastrointestinal and Liver Diseases 18 (2009), 57–60.
3. [3] Das, K., Sarkar, R., Ahmed, S.M., et al. “Normal” liver stiffness measure (LSM) values are higher in both lean and obese individuals: a population-based study from a developing country. Hepatology 55 (2012), 584–593.
4. [4] Baba, M., Furuya, K., Bandou, H., et al. Discrimination of individuals in a general population at high-risk for alcoholic and non-alcoholic fatty liver disease based on liver stiffness: a cross section study. BMC Gastroenterology, 11, 2011, 70.
5. [5] Alsebaey, A., Allam, N., Alswat, K., et al. Normal liver stiffness: a study in living donors with normal liver histology. World Journal of Hepatology 7 (2015), 1149–1153.
6. [6] Roulot, D., Czernichow, S., Le Clésiau, H., et al. Liver stiffness values in apparently healthy subjects: influence of gender and metabolic syndrome. Journal of Hepatology 48 (2008), 606–613.
7. [7] Colombo, S., Belloli, L., Zaccanelli, M., et al. Normal liver stiffness and its determinants in healthy blood donors. Digestive and Liver Disease 43 (2011), 231–236.
8. [8] Kim, B.K., Kim, S.U., Choi, G.H., et al. “Normal” liver stiffness values differ between men and women: a prospective study for healthy living liver and kidney donors in a native Korean population. Journal of Gastroenterology and Hepatology 27 (2012), 781–788.
9. [9] You, S.C., Kim, K.J., Kim, S.U., et al. Factors associated with significant liver fibrosis assessed using transient elastography in general population. World Journal of Gastroenterology 21 (2015), 1158–1166.
10. [10] Wong, G.L., Chan, H.L., Choi, P.C., et al. Association between anthropometric parameters and measurements of liver stiffness by transient elastography. Clinical Gastroenterology and Hepatology 11 (2013), 295–302.
11. [11] Fung, J., Lee, C.K., Chan, M., et al. Defining normal liver stiffness range in a normal healthy Chinese population without liver disease. PLoS ONE, 8, 2013, e85067.
12. [12] Roulot, D., Costes, J.L., Buyck, J.F., et al. Transient elastography as a screening tool for liver fibrosis and cirrhosis in a community-based population aged over 45 years. Gut 60 (2011), 977–984.
13. [13] Petta, S., Di Marco, V., Camma, C., et al. Reliability of liver stiffness measurement in non-alcoholic fatty liver disease: the effects of body mass index. Alimentary Pharmacology and Therapeutics 33 (2011), 1350–1360.
14. [14] Arena, U., Vizzutti, F., Corti, G., et al. Acute viral hepatitis increases liver stiffness values measured by transient elastography. Hepatology 47 (2008), 380–384.
15. [15] Millonig, G., Reimann, F.M., Friedrich, S., et al. Extrahepatic cholestasis increases liver stiffness (FibroScan) irrespective of fibrosis. Hepatology 48 (2008), 1718–1723.
16. [16] Mederacke, I., Wursthorn, K., Kirschner, J., et al. Food intake increases liver stiffness in patients with chronic or resolved hepatitis C virus infection. Liver International 29 (2009), 1500–1506.
17. [17] Lebray, P., Varnous, S., Charlotte, F., et al. Liver stiffness is an unreliable marker of liver fibrosis in patients with cardiac insufficiency. Hepatology, 48, 2008, 2089.
18. [18] Caballeria, L., Pera, G., Auladell, M.A., et al. Prevalence and factors associated with the presence of nonalcoholic fatty liver disease in an adult population in Spain. European Journal of Gastroenterology and Hepatology 22 (2010), 24–32.
19. [19] Browning, J.D., Szczepaniak, L.S., Dobbins, R., et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 40 (2004), 1387–1395.
20. [20] Williams, C.D., Stengel, J., Asike, M.I., et al. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology 140 (2011), 124–131.
21. [21] Koehler, E.M., Plompen, E.P., Schouten, J.N., et al. Presence of diabetes mellitus and steatosis is associated with liver stiffness in a general population: the rotterdam study. Hepatology 63 (2016), 138–147.
22. [22] Wong, V.W., Chu, W.C., Wong, G.L., et al. Prevalence of non-alcoholic fatty liver disease and advanced fibrosis in Hong Kong Chinese: a population study using proton-magnetic resonance spectroscopy and transient elastography. Gut 61 (2012), 409–415.
23. [23] Gaia, S., Carenzi, S., Barilli, A.L., et al. Reliability of transient elastography for the detection of fibrosis in nonalcoholic fatty liver disease and chronic viral hepatitis. Journal of Hepatology 54 (2011), 64–71.
24. [24] Boursier, J., de Ledinghen, V., Sturm, N., et al. Precise evaluation of liver histology by computerized morphometry shows that steatosis influences liver stiffness measured by transient elastography in chronic hepatitis C. Journal of Gastroenterology 49 (2014), 527–537.
25. [25] Macaluso, F.S., Maida, M., Camma, C., et al. Steatosis affects the performance of liver stiffness measurement for fibrosis assessment in patient with genotype 1 chronic hepatitis C. Journal of Hepatology 61 (2014), 523–529.
26. [26] Wong, V.W., Vergniol, J., Wong, G.L., et al. Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease. Hepatology 51 (2010), 454–462.
27. [27] Petta, S., Maida, M., Macaluso, F.S., et al. The severity of steatosis influences liver stiffness measurement in patients with nonalcoholic fatty liver disease. Hepatology 62 (2015), 1101–1110.
28. [28] Matthews, D.R., Hosker, J.P., Rudenski, A.S., et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1985), 412–419.
29. [29] Chalasani, N., The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology. Gastroenterology 142 (2012), 1592–1609.
30. [30] Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults, Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285 (2001), 2486–2497.
31. [31] Saverymuttu, S.H., Joseph, A.E., Maxwell, J.D., Ultrasound scanning in the detection of hepatic fibrosis and steatosis. British Medical Journal 292 (1986), 13–15.
32. [32] Sandrin, L., Fourquet, B., Hasquenoph, J.M., et al. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound in Medicine and Biology 29 (2003), 1705–1713.
33. [33] Nobili, V., Vizzutti, F., Arena, U., et al. Accuracy and reproducibility of transient elastography for the diagnosis of fibrosis in pediatric nonalcoholic steatohepatitis. Hepatology 48 (2008), 442–448.
34. [34] Degos, F., Perez, P., Roche, B., et al. Diagnostic accuracy of FibroScan and comparison to liver fibrosis biomarkers in chronic viral hepatitis: a multicenter prospective study (the FIBROSTIC study). Journal of Hepatology 53 (2010), 1013–1021.
35. [35] Castéra, L., Foucher, J., Bernard, P.H., et al. Pitfalls of liver stiffness measurement: a 5-year prospective study of 13,369 examinations. Hepatology 51 (2010), 828–833.
36. [36] Yasuda, M., Shimizu, I., Shiba, M., et al. Suppressive effects of estradiol on dimethylnitrosamine-induced fibrosis of the liver in rats. Hepatology 29 (1999), 719–727.
37. [37] Liu, Q.H., Li, D.G., Huang, X., et al. Suppressive effects of 17b-estradiol on hepatic fibrosis in CCl4-induced rat model. World Journal of Gastroenterology 10 (2004), 1315–1320.
38. [38] Petta, S., Cammà, C., DI Marco, V., et al. Insulin resistance is a major determinant of liver stiffness in nondiabetic patients with HCV genotype 1 chronic hepatitis. Alimentary Pharmacology and Therapeutics 30 (2009), 603–613.
39. [39] Vincent, M.A., Montagnani, M., Quon, M.J., Molecular and physiologic actions of insulin related to production of nitric oxide in vascular endothelium. Current Diabetes Reports 3 (2003), 279–288.
40. [40] Svegliati-Baroni, G., Ridolfi, F., Di Sario, A., et al. Insulin and insulin-like growth factor-1 stimulate proliferation and type I collagen accumulation by human hepatic stellate cells: differential effects on signal transduction pathways. Hepatology 29 (1999), 1743–1751.
41. [41] Michelotti, G.A., Machado, M.V., Diehl, A.M., NAFLD, NASH and liver cancer. Nature Reviews Gastroenterology and Hepatology 10 (2013), 656–665.
42. [42] Sung, K.C., Wild, S.H., Byrne, C.D., Development of new fatty liver, or resolution of existing fatty liver, over five years of follow-up, and risk of incident hypertension. Journal of Hepatology 60 (2014), 1040–1045.
43. [43] Targher, G., Chonchol, M., Bertolini, L., et al. Increased risk of CKD among type 2 diabetics with nonalcoholic fatty liver disease. Journal of the American Society of Nephrology 19 (2008), 1564–1570.
44. [44] Wong, G.L., Wong, V.W., Chim, A.M., et al. Factors associated with unreliable liver stiffness measurement and its failure with transient elastography in the Chinese population. Journal of Gastroenterology and Hepatology 26 (2011), 300–305.
45. [45] Kim, N.H., Kim, J.H., Kim, Y.J., et al. Clinical and metabolic factors associated with development and regression of nonalcoholic fatty liver disease in non obese subjects. Liver International 34 (2014), 604–611.